China Primary Biliary Cirrhosis Drug Market Research Report 2018

February 2018 | 103 pages | ID: CE11C170F90QEN
QYResearch

Abstracts

The global Primary Biliary Cirrhosis Drug market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Primary Biliary Cirrhosis Drug development status and future trend in China, focuses on top players in China, also splits Primary Biliary Cirrhosis Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• AlbireoPharma
• CymaBay Therapeutics, Inc.
• Dr. Falk Pharma GmbH
• Enanta Pharmaceuticals, Inc.
• GlaxoSmithKline Plc
• Intercept Pharmaceuticals, Inc.
• Johnson & Johnson
• MediGene AG
• NGM Biopharmaceuticals, Inc.
• Virobay Inc.

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Budesonide
• FFP-104
• GSK-2330672
• MBX-8025
• NGM-282
• Others

On the basis of the end users/application, this report covers

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Primary Biliary Cirrhosis Drug Market Research Report 2017

1 PRIMARY BILIARY CIRRHOSIS DRUG OVERVIEW

1.1 Product Overview and Scope of Primary Biliary Cirrhosis Drug
1.2 Classification of Primary Biliary Cirrhosis Drug by Product Category
  1.2.1 China Primary Biliary Cirrhosis Drug Sales (K Pcs) Comparison by Type (2012-2022)
  1.2.2 China Primary Biliary Cirrhosis Drug Sales (K Pcs) Market Share by Type in 2016
  1.2.3 Budesonide
  1.2.4 FFP-104
  1.2.5 GSK-2330672
  1.2.6 MBX-8025
  1.2.7 NGM-282
  1.2.8 Others
1.3 China Primary Biliary Cirrhosis Drug Market by Application/End Users
  1.3.1 China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 China Primary Biliary Cirrhosis Drug Market by Region
  1.4.1 China Primary Biliary Cirrhosis Drug Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
  1.4.3 East China Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
  1.4.4 Southwest China Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
  1.4.5 Northeast China Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
  1.4.6 North China Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
  1.4.7 Central China Primary Biliary Cirrhosis Drug Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Primary Biliary Cirrhosis Drug (2012-2022)
  1.5.1 China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)
  1.5.2 China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA PRIMARY BILIARY CIRRHOSIS DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Primary Biliary Cirrhosis Drug Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Primary Biliary Cirrhosis Drug Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Primary Biliary Cirrhosis Drug Market Competitive Situation and Trends
  2.4.1 China Primary Biliary Cirrhosis Drug Market Concentration Rate
  2.4.2 China Primary Biliary Cirrhosis Drug Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Primary Biliary Cirrhosis Drug Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA PRIMARY BILIARY CIRRHOSIS DRUG SALES AND REVENUE BY REGION (2012-2017)

3.1 China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Regions (2012-2017)

4 CHINA PRIMARY BILIARY CIRRHOSIS DRUG SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Type (2012-2017)
4.4 China Primary Biliary Cirrhosis Drug Sales Growth Rate (%) by Type (2012-2017)

5 CHINA PRIMARY BILIARY CIRRHOSIS DRUG SALES BY APPLICATION (2012-2017)

5.1 China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Primary Biliary Cirrhosis Drug Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA PRIMARY BILIARY CIRRHOSIS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AlbireoPharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CymaBay Therapeutics, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Dr. Falk Pharma GmbH
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Enanta Pharmaceuticals, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline Plc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Intercept Pharmaceuticals, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 MediGene AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 NGM Biopharmaceuticals, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Virobay Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Primary Biliary Cirrhosis Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview

7 PRIMARY BILIARY CIRRHOSIS DRUG MANUFACTURING COST ANALYSIS

7.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Primary Biliary Cirrhosis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA PRIMARY BILIARY CIRRHOSIS DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Primary Biliary Cirrhosis Drug Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Primary Biliary Cirrhosis Drug Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Primary Biliary Cirrhosis Drug
Table China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share by Types in 2016
Figure Budesonide Product Picture
Figure FFP-104 Product Picture
Figure GSK-2330672 Product Picture
Figure MBX-8025 Product Picture
Figure NGM-282 Product Picture
Figure Others Product Picture
Figure China Primary Biliary Cirrhosis Drug Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Primary Biliary Cirrhosis Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Primary Biliary Cirrhosis Drug Sales of Key Players/Manufacturers (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Primary Biliary Cirrhosis Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Primary Biliary Cirrhosis Drug Sales Share (%) by Players/Manufacturers
Table China Primary Biliary Cirrhosis Drug Revenue by Players/Manufacturers (2012-2017)
Table China Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Primary Biliary Cirrhosis Drug Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Primary Biliary Cirrhosis Drug Average Price of Key Players/Manufacturers in 2016
Figure China Primary Biliary Cirrhosis Drug Market Share of Top 3 Players/Manufacturers
Figure China Primary Biliary Cirrhosis Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Primary Biliary Cirrhosis Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Primary Biliary Cirrhosis Drug Product Category
Table China Primary Biliary Cirrhosis Drug Sales (K Pcs) by Regions (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Share (%) by Regions (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Share (%) by Regions (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Market Share (%) by Regions in 2016
Table China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Regions (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Regions in 2016
Table China Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Regions (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales (K Pcs) by Type (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Share (%) by Type (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Share (%) by Type (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Market Share (%) by Type in 2016
Table China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Primary Biliary Cirrhosis Drug Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Type (2012-2017)
Figure Revenue Market Share of Primary Biliary Cirrhosis Drug by Type in 2016
Table China Primary Biliary Cirrhosis Drug Price (USD/Pcs) by Types (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Growth Rate (%) by Type (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales (K Pcs) by Applications (2012-2017)
Table China Primary Biliary Cirrhosis Drug Sales Market Share (%) by Applications (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Market Share (%) by Application (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Market Share (%) by Application in 2016
Table China Primary Biliary Cirrhosis Drug Sales Growth Rate (%) by Application (2012-2017)
Figure China Primary Biliary Cirrhosis Drug Sales Growth Rate (%) by Application (2012-2017)
Table AlbireoPharma Primary Biliary Cirrhosis Drug Basic Information List
Table AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Basic Information List
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Basic Information List
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Basic Information List
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table MediGene AG Primary Biliary Cirrhosis Drug Basic Information List
Table MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure MediGene AG Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table Virobay Inc. Primary Biliary Cirrhosis Drug Basic Information List
Table Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Sales Market Share (%) in China (2012-2017)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Biliary Cirrhosis Drug
Figure Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
Figure Primary Biliary Cirrhosis Drug Industrial Chain Analysis
Table Raw Materials Sources of Primary Biliary Cirrhosis Drug Major Players/Manufacturers in 2016
Table Major Buyers of Primary Biliary Cirrhosis Drug
Table Distributors/Traders List
Figure China Primary Biliary Cirrhosis Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Type in 2022
Table China Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Market Share Forecast by Application in 2022
Table China Primary Biliary Cirrhosis Drug Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions (2017-2022)
Figure China Primary Biliary Cirrhosis Drug Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources